Global Autotransfusion Devices Market 2021 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Autotransfusion Devices Market 2021 (Includes Business Impact of COVID-19)
Global Autotransfusion Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2030 is a recent report generated by Trusted Business Insights. The global autotransfusion devices market report has been segmented on the basis of technique, application, end user, and region
Request Covid - 19 Impact
The global Autotransfusion Devices market size was valued at USD $837.29 million in 2020 and is projected to reach $1515.16 million by 2030, and is anticipated to expand at a CAGR of 5.57% over the forecast period from 2020 to 2030.


Global Autotransfusion Devices Market: Overview


Autotransfusion devices are intelligent, easy, and adaptable auto-transfusion systems that are designed to deliver high-quality blood product during surgeries. There is a continuous increase in the number of patients suffering from heart associated disease along with an increase in the number of surgeries related to orthopedics, neurosurgery, vascular surgery, etc. Adoption of such advanced devices during surgeries helps the surgeon to complete the surgery with further complication. These devices help to minimize blood waste and retain high-quality blood.


Global Autotransfusion Devices Market: Dynamics


Rising incidences of chronic diseases across the globe and increasing adoption of autotransfusion devices by hospitals that aid in returning washed red blood cells to a patient during surgery are major factors expected to drive growth of the global autotransfusion devices market.

In addition, rising number of patients suffering from heart associated diseases, rinsing number of surgeries such as cardiopulmonary bypass, orthopedics, neurosurgery, vascular surgery, and urology is resulting in rising demand for auto-transfusion devices that aid in successful surgery without any complication is among other factors expected to support growth of the global autotransfusion market.

Moreover, increasing government expenditure on the development of healthcare infrastructure in order to facilitate the adoption of advanced medical devices is another factor expected to further boost growth of the target market.

However, high-cost of devices is a major factor expected to hamper growth of the global autotransfusion market. In addition, stringent government regulations related to product approval and lack of developed infrastructure in developing countries in order to facilitate the adoption are some other factors expected to challenge growth of the global market to a certain extent.

Increasing investment by major players for technological advancements and R&D activities and the development of cost-effective medical devices are expected to create new opportunities in terms of revenue for players operating in the target market. In addition, increasing expansion activities by major players through partnership and agreements in order to increase their customer base is expected to further support the market growth.


Global Autotransfusion Devices Market: Segment


Among the application segments, the cardiac segment is expected to dominate in the target market over the forecast period.

Among the end user segments, the hospital segment is expected to dominate in the target market over the forecast period.


Global Autotransfusion Devices Market: Region


The market in North America is expected to dominate in the global autotransfusion market and is expected to continue its dominance over the forecast period. This dominance can be attributed to well-developed healthcare infrastructure for R&D activities and facilitate the adoption of advanced medical devices and the presence of major players operating in countries in this region. In addition, growing merger and acquisition activities between regional and international players are expected to further boost the market growth in this region. In 2019, OHK Medical Devices Inc. has created a new device called HemaShock-it acts as an autotransfusion device redirecting blood from one or both legs about a half liter per leg to essential organs.

The market in Asia Pacific is expected to faster growth, owing to increasing government spending on the healthcare sector, high number of cardiopulmonary bypass, orthopedic surgeries, and presence of prominent players operating in emerging economies in this region.

Global Autotransfusion Devices Market Segmentation:

Segmentation by techniques:

  
Predeposit transfusion
  
Intraoperative haemodilution
  
Intraoperative and postoperative salvage

Segmentation by application

  
Cardiac
  
Vascular
  
Orthopedic
  
Trauma surgery
  
Liver Transplantation

Segmentation by end user

  
Hospitals
  
Ambulatory Surgical Centers
  
Emergency Rooms


Key Market Players included in the report:


  


  
Advancis Surgical
  
Atrium Medical and Advancis Surgical.
  
Becton Dickinson and Company
  
Brightwake
  
Dickinson and Company
  
Fresenius Medical Care AG & Co. KGaA
  
Getinge AB
  
Haemonetics Corporation
  
LivaNova Plc
  
Medtronic Plc
  
Stryker Corporation




  
Teleflex Incorporated
  
Terumo Corporation and Getinge AB.
  
Zimmer Biomet Holding


Below are the key development related to Autotransfusion Devices Market in 2020 and 2021.


June 2020: ProCell Surgical Inc. announced the launch of ProCell™, a proprietary, first-to-market medical device designed to effectively automate the manual and outdated activity of surgical sponge-blood recovery for intraoperative autotransfusion (IAT). ProCells unique patented design enhances a hospitals surgical blood conservation efforts by utilizing an operating rooms standard vacuum suction to apply a sustained compressive force that effectively extracts blood from surgical sponges. The recovered blood is then sent to the cell saver equipment via its own suction tubing where it is processed before being reinfused into the patient during that same surgical procedure. Source